Immediate Impact
43 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
The immunostimulatory nature of mRNA lipid nanoparticles
2024 Standout
Works of Takeo Otsuki being referenced
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
2017
What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Takeo Otsuki | 201 | 102 | 166 | 166 | 21 | 422 | |
| Akihiko Hashi | 189 | 185 | 140 | 218 | 27 | 467 | |
| Ian Harley | 232 | 139 | 206 | 155 | 24 | 489 | |
| Meagan Judge | 106 | 103 | 130 | 67 | 17 | 381 | |
| Yasushi Mabuchi | 202 | 70 | 166 | 69 | 30 | 426 | |
| Richard L. Voet | 106 | 135 | 106 | 79 | 25 | 505 | |
| Mary C. Bibro | 150 | 168 | 128 | 89 | 19 | 456 | |
| Nae-Fang Twu | 184 | 154 | 178 | 108 | 30 | 482 | |
| Eren Demirtaş | 110 | 120 | 78 | 135 | 24 | 385 | |
| Chiung‐Ru Lai | 101 | 111 | 113 | 127 | 23 | 489 | |
| Karim ElSahwi | 178 | 111 | 108 | 65 | 23 | 503 |
All Works
Loading papers...